PAPER Bainbridge WA, Berron D, Schütze H, Cardenas-Blanco A, Metzger C, Dobisch L, Bittner D, Glanz W, Spottke A, Rudolph J, Brosseron F, Buerger K, Janowitz D, Fliessbach K, Heneka M, Laske C, Buchmann M, Peters O, Diesing D, Li S, Priller J, Spruth EJ, Altenstein S, Schneider A, Kofler B, Teipel S, Kilimann I, Wiltfang J, Bartels C, Wolfsgruber S, Wagner M, Jessen F, Baker CI, Düzel E
SEARCH RESULTS
1092 RESULTS
PAPER Barupal DK, Baillie R, Fan S, Saykin AJ, Meikle PJ, Arnold M, Nho K, Fiehn O, Kaddurah-Daouk R, Alzheimer Disease Metabolomics Consortium
Sets of coregulated serum lipids are associated with Alzheimer's disease pathophysiology.
Alzheimers Dement (Amst). 2019 Dec;11:619-627. Epub 2019 Sep 5 PubMed: 31517024PAPER Clouston SA, Diminich ED, Kotov R, Pietrzak RH, Richards M, Spiro A 3rd, Deri Y, Carr M, Yang X, Gandy S, Sano M, Bromet EJ, Luft BJ
Incidence of mild cognitive impairment in World Trade Center responders: Long-term consequences of re-experiencing the events on 9/11/2001.
Alzheimers Dement (Amst). 2019 Dec;11:628-636. Epub 2019 Sep 6 PubMed: 31517025PAPER Dallaire-Théroux C, Beheshti I, Potvin O, Dieumegarde L, Saikali S, Duchesne S, Alzheimer's Disease Neuroimaging Initiative
Braak neurofibrillary tangle staging prediction from in vivo MRI metrics.
Alzheimers Dement (Amst). 2019 Dec;11:599-609. Epub 2019 Sep 4 PubMed: 31517022PAPER Donnelly-Kehoe PA, Pascariello GO, García AM, Hodges JR, Miller B, Rosen H, Manes F, Landin-Romero R, Matallana D, Serrano C, Herrera E, Reyes P, Santamaria-Garcia H, Kumfor F, Piguet O, Ibanez A, Sedeño L
Robust automated computational approach for classifying frontotemporal neurodegeneration: Multimodal/multicenter neuroimaging.
Alzheimers Dement (Amst). 2019 Dec;11:588-598. Epub 2019 Aug 28 PubMed: 31497638PAPER Eruysal E, Ravdin L, Kamel H, Iadecola C, Ishii M
Plasma lipocalin-2 levels in the preclinical stage of Alzheimer's disease.
Alzheimers Dement (Amst). 2019 Dec;11:646-653. Epub 2019 Sep 6 PubMed: 31517027PAPER Wen Q, Mustafi SM, Li J, Risacher SL, Tallman E, Brown SA, West JD, Harezlak J, Farlow MR, Unverzagt FW, Gao S, Apostolova LG, Saykin AJ, Wu YC
White matter alterations in early-stage Alzheimer's disease: A tract-specific study.
Alzheimers Dement (Amst). 2019 Dec;11:576-587. Epub 2019 Aug 21 PubMed: 31467968PAPER Ziontz J, Bilgel M, Shafer AT, Moghekar A, Elkins W, Helphrey J, Gomez G, June D, McDonald MA, Dannals RF, Azad BB, Ferrucci L, Wong DF, Resnick SM
Tau pathology in cognitively normal older adults.
Alzheimers Dement (Amst). 2019 Dec;11:637-645. Epub 2019 Sep 6 PubMed: 31517026PAPER Forsyth K, Henderson C, Davis L, Singh Roy A, Dunk B, Curnow E, Gathercole R, Lam N, Harper E, Leroi I, Woolham J, Fox C, O'Brien J, Bateman A, Poland F, Bentham P, Burns A, Davies A, Gray R, Bradley R, Knapp M, Newman S, McShane R, Ritchie C, Talbot E, Hooper E, Winson R, Scutt B, Ordonez V, Nunn S, Lavelle G, Howard R
Assessment of need and practice for assistive technology and telecare for people with dementia-The ATTILA (Assistive Technology and Telecare to maintain Independent Living At home for people with dementia) trial.
Alzheimers Dement (N Y). 2019;5:420-430. Epub 2019 Sep 3 PubMed: 31517029PAPER Gaugler JE, Bain LJ, Mitchell L, Finlay J, Fazio S, Jutkowitz E, Alzheimer's Association Psychosocial Measurement Workgroup
Reconsidering frameworks of Alzheimer's dementia when assessing psychosocial outcomes.
Alzheimers Dement (N Y). 2019;5:388-397. Epub 2019 Aug 17 PubMed: 31463361PAPER Nicodemus NE, Becerra S, Kuhn TP, Packham HR, Duncan J, Mahdavi K, Iovine J, Kesari S, Pereles S, Whitney M, Mamoun M, Franc D, Bystritsky A, Jordan S
Focused transcranial ultrasound for treatment of neurodegenerative dementia.
Alzheimers Dement (N Y). 2019;5:374-381. Epub 2019 Aug 8 PubMed: 31440580PAPER Tian J, Shi J, Wei M, Ni J, Fang Z, Gao J, Wang H, Yao H, Zhang J, Li J, Min M, Su L, Sun X, Wang B, Wang B, Yang F, Zou Y, Hu Y, Lin Y, Xu G, Li K, Li L, Zhen H, Xu J, Chen K, Wang Y, CHARM study group
Chinese herbal medicine Qinggongshoutao for the treatment of amnestic mild cognitive impairment: A 52-week randomized controlled trial.
Alzheimers Dement (N Y). 2019;5:441-449. Epub 2019 Sep 4 PubMed: 31517031PAPER Wang G, Aschenbrenner AJ, Li Y, McDade E, Liu L, Benzinger TL, Bateman RJ, Morris JC, Hassenstab JJ, Xiong C
Two-period linear mixed effects models to analyze clinical trials with run-in data when the primary outcome is continuous: Applications to Alzheimer's disease.
Alzheimers Dement (N Y). 2019;5:450-457. Epub 2019 Sep 5 PubMed: 31517032PAPER Watanabe M, Nakamura Y, Yoshiyama Y, Kagimura T, Kawaguchi H, Matsuzawa H, Tachibana Y, Nishimura K, Kubota N, Kobayashi M, Saito T, Tamura K, Sato T, Takahashi M, Japanese Society of Scaling Keys of Evaluation Techniques for CNS Disorders Heterogeneity (SKETCH) study group, Homma A
Analyses of natural courses of Japanese patients with Alzheimer's disease using placebo data from placebo-controlled, randomized clinical trials: Japanese Study on the Estimation of Clinical course of Alzheimer's disease.
Alzheimers Dement (N Y). 2019;5:398-408. Epub 2019 Aug 29 PubMed: 31517028PAPER Wittenberg R, Knapp M, Karagiannidou M, Dickson J, Schott J